Navigation Links
Phase III study finds investigational agent empagliflozin significantly reduced blood glucose in adults with type 2 diabetes and impaired kidney function
Date:6/22/2013

betes Federation. Diabetes Atlas, 5th Edition: Fact Sheet. 2012.
  • International Diabetes Federation. Diabetes Atlas, 5th Edition: What is Diabetes? http://www.idf.org/diabetesatlas/5e/what-is-diabetes.  Accessed on: June 18, 2013.
  • American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36(4):1033-1046.
  • *Empagliflozin is an investigational compound. Its safety and efficacy have not been established.

    (Logo: http://photos.prnewswire.com/prnh/20110825/DE57898LOGO )
    (Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )


    '/>"/>
    SOURCE Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
    2. Phase III data show investigational compound empagliflozin significantly reduced blood glucose in adults with type 2 diabetes
    3. Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541
    4. Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
    5. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
    6. Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine
    7. Safinamide Phase III Study Results Presented at 2013 MDS Meeting
    8. Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinsons Disease
    9. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
    10. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
    11. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/5/2015)...  Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage ... therapeutics including high value and difficult to manufacture ... full year 2014 financial results will be released ... opens for trading.  At 9:00 am Eastern Time, ... discuss the financial results and provide a business ...
    (Date:3/5/2015)... and TÜBINGEN, Germany ... & Melinda Gates Foundation and CureVac today announced ... invest $52 million (€46 million) in CureVac, a ... technologies. As part of the agreement, the foundation ... to develop prophylactic vaccines based on CureVac,s proprietary ...
    (Date:3/5/2015)... 5, 2015  Sanomedics, Inc. (OTC: SIMH, SIMHD) ("Sanomedics" ... on developing, manufacturing, and acquiring cutting-edge technology, products and ... will be exhibiting at booth # 709 at the ... (NAPNAP) taking place on March 11-13, 2015 at Caesars ... The 36 th annual NAPNAP ...
    Breaking Medicine Technology:Pfenex To Report Fourth Quarter and Full Year 2014 Results and Provide Business Update 2The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 2The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 3The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 4Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 3
    (Date:3/5/2015)... 2015 A Bakersfield, Calif. state court jury ... trial awarding the plaintiff Coleen M. Perry a total of ... a TVT-Abbrevo pelvic mesh sling device, manufactured by Ethicon, Inc., ... , a partner at Wagstaff & Cartmell in ... plaintiff, along with Rich Freese and Tim Goss of ...
    (Date:3/5/2015)... New York, NY (PRWEB) March 05, 2015 ... to move forward in a Pennsylvania mass tort ... Common Pleas, where a jury has begun hearing ... allegations that the atypical antipsychotic medication can cause ... documents, the case in question was filed on ...
    (Date:3/5/2015)... 05, 2015 Central Nebraska Imaging (CNI) ... including the brand’s new logo and optimized website. ... practice’s modern approach to expert diagnostic imaging, centered on ... be built to be a resource for Nebraska patients ... automated forms, communication and referral functionality, video content and ...
    (Date:3/5/2015)... HomeCEUConnection.com is proud to ... savings on their nutrition CEUs. To raise ... nutrition, HomeCEUConnection.com is offering 10% off selected ... NUTRITION2015 . , High Quality Continuing ... provides high-quality continuing education courses for Physical ...
    (Date:3/5/2015)... 2015 On March 2, 2015, NBC ... on the Rise, Plastic Surgeons Say,” that comments on ... for Aesthetic Plastic Surgery and the American ... a year-over-year doubling of surgical butt augmentations performed in ... the article, this increase can be attributed to the ...
    Breaking Medicine News(10 mins):Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2
    ... reverse the health threats, experts say , , THURSDAY, Sept. 20 ... to control their weight by watching their cholesterol by cutting ... total calories and physical activity. And guess what happened to ... an end run around the issue of health maintenance," said ...
    ... scientific researchers: SNM invites you to present your ... molecular imaging techniques and agents -- at the ... New Orleans, La. SNM, the worlds largest society ... showcase these studies in a new scientific investigation ...
    ... 20, 2007 Defects on cell-surface sugars may promote ... the central nervous system of multiple sclerosis patients, according ... also suggest that a dietary supplement similar to glucosamine ... these defects and to treat both the short-term and ...
    ... is challenging conventional thinking on how the cholesterol-reducing drugs ... investigate her findings. , Dr Sarah Calaghan from the ... from Heart Research UK to progress her preliminary evidence ... , For a long time the cardiovascular ...
    ... RFID-based inventory management solution is installed ... track critical medical supplies., BOXBOROUGH, Mass., Sept. 20 ... highest level of care, UMass Memorial Medical Center,located in ... Massachusetts, has installed WaveMark CIMS(TM), an RFID-based,inventory management solution ...
    ... Makes ,House Call, to New Mexico, Urges Residents to Also Press ... ... Sept. 20 The American,Medical Association (AMA) National House Call campaign ... stop scheduled Medicare,cuts. Unless Congress intervenes, Medicare will slash physician payments ...
    Cached Medicine News:Health News:Childhood Obesity Epidemic a Long-Term Challenge 2Health News:Childhood Obesity Epidemic a Long-Term Challenge 3Health News:SNM seeks novel approaches to molecular imaging to showcase at annual meeting 2Health News:Cell-surface sugar defects may trigger nerve damage in multiple sclerosis patients 2Health News:Research to shed new light on how statins benefit heart patients 2Health News:WaveMark, Inc. is Chosen by UMass Memorial Medical Center 2Health News:AMA Urges Congress to Stop Medicare Cuts 2
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: